-
公开(公告)号：US2937974A
公开(公告)日：1960-05-24
申请号：US71353258
申请日：1958-02-06
申请人： FERGUSON JR EDGAR A
发明人： FERGUSON JR EDGAR A
CPC分类号： A61Q19/00 , A61K8/64 , A61K38/018 , A61K2800/75
-
公开(公告)号：US2666013A
公开(公告)日：1954-01-12
申请号：US18157350
申请日：1950-08-25
申请人： FERGUSON JR EDGAR A
发明人： FERGUSON JR EDGAR A
CPC分类号： A61K38/018 , A61K9/0014 , A61K47/10 , Y10S514/827 , Y10S514/848
-
公开(公告)号：US12059016B2
公开(公告)日：2024-08-13
申请号：US15527860
申请日：2015-11-09
IPC分类号： A23L33/19 , A23C9/13 , A23K20/147 , A23K20/163 , A23L33/00 , A23L33/21 , A61K35/20 , A61K38/01
CPC分类号： A23L33/19 , A23C9/1307 , A23K20/147 , A23K20/163 , A23L33/21 , A23L33/30 , A23L33/40 , A61K35/20 , A61K38/018 , A23V2002/00 , A23V2200/00 , A23V2002/00 , A23V2200/00 , A23V2200/316 , A23V2250/5072 , A23V2250/54252 , A61K38/018 , A61K2300/00
摘要： The present invention relates to the treatment or prevention of conditions linked to reduced muscle mass or reduced muscle protein synthesis rate. A subject matter of the invention is a composition comprising complexes of whey protein micelles and pectin for use in the treatment or prevention of a condition selected from the group consisting of sarcopenia, muscle atrophy and negative nitrogen balance. Further aspects of the invention relate to the non-therapeutic use of a composition comprising complexes of whey protein micelles and pectin and a food composition.
-
公开(公告)号：US20230380445A1
公开(公告)日：2023-11-30
申请号：US18032481
申请日：2020-12-18
发明人： Kwanhyoung LEE , Ara KIM , Juyeon LEE , Hyuncheol JANG , Youngbeom KIM , Daebang SEO
摘要： The present invention relates to a whey-derived polar lipid-concentrated fraction composition, being a single-phase composition derived from a whey protein concentrate, wherein the composition is derived from a fraction obtained by treating the whey protein concentrate with a water-containing spirit, a total lipid content is 90 percent by weight (wt %) or more with respect to a dry weight of the composition, and a phospholipid content is 35 wt % or more with respect to the total lipid weight. According to the present invention, a whey-derived polar lipid-concentrated fraction composition in a stable form that maximizes emulsification and physiological functionality may be prepared.
-
85.发明公开公开(公告)号：US20230338404A1
公开(公告)日：2023-10-26
申请号：US18345357
申请日：2023-06-30
申请人： ABBOTT LABORATORIES
IPC分类号： A61K31/702 , A23L33/00 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/01
CPC分类号： A61K31/702 , A23L33/40 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/30 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/018 , A23V2002/00 , A61K2035/115
摘要： Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
-
公开(公告)号：US11785976B2
公开(公告)日：2023-10-17
申请号：US17233716
申请日：2021-04-19
发明人： Teartse Tim Lambers , Cindy van Bommel , Zihua Ao , Anja Wittke , Kelly Alina Dingess , Kasper Hettinga
CPC分类号： A23L33/40 , A23J3/344 , A23L33/18 , A23L33/19 , A61K38/018 , A23Y2220/73
摘要： The present disclosure generally relates to methods of preparing protein hydrolysates for use in pediatric nutritional compositions. Specifically, alpha-, beta- and/or kappa casein enriched casein, acid casein or caseinates can be hydrolyzed with proteases such as trypsin (trypsin-like), chymotrypsin (chymotrypsin-like), pepsin and/or plasmin to produce a hydrolysate that is close to the peptide composition of human breast milk.
-
87.发明公开公开(公告)号：US20230285321A1
公开(公告)日：2023-09-14
申请号：US18199523
申请日：2023-05-19
发明人： Gabriele Civiletto , Bernard Cuenoud , Jerome Feige , Philipp Gut
IPC分类号： A61K31/132 , A61K31/19 , A61K38/01 , A61K38/17
CPC分类号： A61K31/132 , A61K31/19 , A61K38/011 , A61K38/018 , A61K38/1709
摘要： Compositions and methods can use a combination of an autophagy inducer, such as spermidine, and high protein for induction of autophagy in an individual in need thereof. Preferably, a formulation containing a combination of an autophagy inducer and high protein is administered to the individual in an amount effective to induce autophagy, for example in muscle. The formulation can concomitantly promote protein synthesis and removal of damaged cellular materials. The recipient of administration can be a critically ill patient, for example a patient in the Intensive Care Unit (ICU), and/or an ageing patient, for example an elderly individual or an individual with sarcopenia.
-
公开(公告)号：US11690859B2
公开(公告)日：2023-07-04
申请号：US16698422
申请日：2019-11-27
申请人： ABBOTT LABORATORIES
IPC分类号： A61K31/70 , A01N43/04 , A61K31/702 , A23L33/00 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/01 , A61K35/00
CPC分类号： A61K31/702 , A23L33/10 , A23L33/12 , A23L33/135 , A23L33/19 , A23L33/30 , A23L33/40 , A61K9/107 , A61K31/716 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/018 , A61K45/06 , A23V2002/00 , A61K2035/11 , A61K2035/115 , A61K31/702 , A61K2300/00 , A61K31/716 , A61K2300/00 , A23V2002/00 , A23V2200/32 , A23V2250/282
摘要： Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
-
公开(公告)号：US20180344772A1
公开(公告)日：2018-12-06
申请号：US15527804
申请日：2015-11-09
申请人： NESTEC S.A.
发明人： Christophe Joseph Etienne Schmitt , Etienne Pouteau , Simina Florentina Popa Nita , Laurence Donato-Capel , Lionel Jean Rene Bovetto
CPC分类号： A61K35/20 , A23C9/1307 , A23C9/137 , A23C21/08 , A23L33/19 , A23V2002/00 , A23V2200/00 , A23V2200/328 , A23V2250/50366 , A23V2250/5072 , A23V2250/54252 , A61K9/10 , A61K9/1075 , A61K31/718 , A61K31/723 , A61K31/731 , A61K31/732 , A61K31/734 , A61K38/018 , A61K47/36 , A61K2300/00 , A61P3/10 , A23V2250/50
摘要： The present invention relates to a composition comprising polysaccharides and whey protein micelles for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising polysaccharides and whey protein micelles to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming polysaccharide-whey protein micelle complexes.
-
90.发明申请公开(公告)号：US20180325157A1
公开(公告)日：2018-11-15
申请号：US15775002
申请日：2016-11-10
发明人： Torres Sweeney , John O'Doherty
IPC分类号： A23L33/18 , A23L33/21 , A23L33/19 , A23L33/14 , A23L33/00 , A61K31/716 , A23K20/147 , A23K20/163 , A23K50/30 , A23K50/60
CPC分类号： A23L33/18 , A23K20/147 , A23K20/163 , A23K50/30 , A23K50/60 , A23L29/269 , A23L29/271 , A23L29/281 , A23L33/14 , A23L33/19 , A23L33/21 , A23L33/40 , A23V2002/00 , A23V2200/32 , A23V2250/218 , A23V2250/5034 , A23V2250/54246 , A23V2250/55 , A61K31/716 , A61K38/018 , A61K2300/00
摘要： A non-therapeutic method of improving growth performance of a weaning mammal comprises a step of administering to the weaning mammal or a maternal mammal an effective amount of beta-glucan and casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1. A dietary supplement suitable for oral administration to a mammal comprising beta-glucan and casein hydrolysate is also provided, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1.
-
-
-
-
-
-
-
-
-
搜索结果
470 条记录 (耗时 0.021 秒)
